Life Sciences
Pitch Deck
Design

Biotech founders, scientific communications teams, and investor relations teams use our life sciences pitch deck design service to clarify complex science, organize clinical evidence, and prepare investor presentations for fundraising and partnership discussions.

Check Dark Mode Icon - Subscription X Webflow Template

Fully editable and animated PowerPoint presentations.

Check Dark Mode Icon - Subscription X Webflow Template

Structured to communicate clinical milestones, mechanism of action, and commercialization strategy to investors.

Check Dark Mode Icon - Subscription X Webflow Template

Prepared for Series A, Series B, venture capital meetings, and partnership discussions.

Start a Project

Challenges of
Pitch Decks Design for Life Sciences

Most life sciences pitch decks contain strong science but lose investor attention before the commercial opportunity becomes clear. These are the most common communication challenges biotech, medtech, and healthcare teams face when preparing for fundraising conversations.

Challenge

Strong Science Can Be Difficult for Investors to Understand Quickly

Biotech and healthcare teams often explain the science in great detail, but investors still struggle to quickly understand why the opportunity matters commercially. The science may be credible, yet the investment opportunity is not immediately clear inside the presentation.

Our Approach

We Structure the Presentation Around What Investors Need to Understand

We organize the presentation so investors can quickly understand the problem, scientific solution, market opportunity, and business potential without getting lost in deep Scintifiv  detail.
Clinical data and scientific information are organized to support faster investor comprehension and clearer evaluation.

Challenge

One Deck Must Satisfy Multiple Audiences

Life sciences pitch decks are often reviewed by venture capital investors, scientific advisors, pharmaceutical partners, and commercial stakeholders at different stages of the fundraising process. Balancing scientific credibility with investor readability inside a single presentation is genuinely difficult.

Our Approach

A Presentation Structured for Scientific and Commercial Audiences

We build presentations using a layered information hierarchy that establishes scientific credibility early while progressively introducing the commercial logic behind the opportunity. This helps scientific and commercial audiences follow the presentation without losing context

Challenge

Long Clinical Timelines with No Near-Term Revenue

Communicating value across lengthy clinical, regulatory, and commercialization timelines is one of the biggest challenges in biotech fundraising. Companies often need to maintain investor confidence during phases where meaningful revenue has not yet materialized.

Our Approach

Clinical Progress Presented as a Sequence of Value Milestones

We frame the development roadmap around investor-relevant milestones. Regulatory progression, clinical readouts, partnerships, and commercialization triggers are positioned as value inflection points that demonstrate momentum and reduce perceived investment uncertainty.

Who is this service for?

Life sciences fundraising depends on the people who carry the science into the investor room and translate clinical innovation into a case for investment.

For Biotech Founders and Executive Teams

For Biotech Founders and Executive TeamsFounders, CEOs, and CSOs preparing for Series A, Series B, and venture capital discussions need a deck that communicates scientific value and commercial opportunity clearly.
We structure the investor presentation around the fundraising stage and the audience in the room

For Scientific Founders and Research-Led Startups

Teams translating platform technologies, clinical innovation, and early-stage science into investor-facing presentations often carry the strongest science and the least investor narrative. We build that narrative from the clinical materials they already have.

For Investor Relations and Scientific Communications Teams

Teams responsible for communicating clinical progress, market opportunity, and strategic growth stories to investors and partners need presentation assets that are accurate, clear, and ready for high-stakes discussions. We prepare presentations that hold up to detailed scientific scrutiny.

For Pharmaceutical Spinouts and Research Ventures

Pharmaceutical spinouts and research ventures reframing internal scientific programs into external investment opportunities need presentations that speak to commercial investors rather than internal review committees. We restructure existing clinical materials around the fundraising objective.

Our Life Sciences Pitch Deck design process

Presentile combines scientific storytelling and pharma communication design to help healthcare teams present products, data, and medical information more clearly.

01

Understanding Goals and Innovation Story

Meeting with your team to understand the science, audience, commercialization priorities, and presentation objectives before presentation development begins.

02

Building Three Presentation Directions

We create three presentation directions based on your scientific communication goals, audience, and commercialization strategy. Once a direction is approved, we develop the presentation using custom visuals prepared for easier reuse and ownership management.

03

Review and Presentation Alignment

We create three presentation directions based on your scientific communication goals, audience, and commercialization strategy. Once a direction is approved, we develop the presentation using custom visuals prepared for easier reuse, copyright management.

04

Final Delivery

We deliver the completed presentation in fully editable PowerPoint format, prepared for future presentation updates and ongoing investor and partnership communication.

Frequently asked questions

Here you are a list of the questions we frequently hear from our customers

01

What is a life sciences pitch deck?

A life sciences pitch deck is an investor presentation built specifically for biotech, medtech, and healthcare companies raising funds or seeking partnerships. It translates complex science, clinical data, and development timelines into a clear commercial case that investors can evaluate and act on.

02

Do you use in-house designers or freelancers?

We only work with our in-house medically graduated team. Because we sign an NDA before any materials are shared, we never pass your science or clinical data to freelancers.

03

What makes your life sciences pitch deck design different from other design agencies?

The scientific content is structured around the commercial opportunity, not presented in parallel to it. Clinical data, mechanism of action, and platform differentiation are built to support the investment case at each stage of the presentation. Investors follow the science more confidently when the commercial logic is visible throughout rather than introduced only at the end of the presentation.

04

How do you balance scientific credibility with investor readability in a single presentation?

The presentation is built with a clear information hierarchy. Scientific credibility is established early through evidence quality, clinical data presentation, and development stage clarity. The commercial logic is then layered progressively so investors can follow the opportunity without working through dense clinical context first.

05

Do you sign an NDA before the project starts?

Yes. We sign an NDA before any materials are shared with us. No scientific data, clinical findings, or fundraising documents are reviewed until the agreement

06

Can the same presentation be adapted for different fundraising audiences?

Yes. Because all files are delivered in fully editable PowerPoint format, the core presentation can be adapted for seed investors, venture capital audiences, pharmaceutical partners, and licensing discussions without rebuilding from scratch for every discussion. The commercial logic, milestone emphasis, and market opportunity framing are adjusted for each specific audience.

07

Can you redesign an existing deck rather than build from scratch?

Both. We can restructure an existing presentation around a stronger investor narrative, or build from your raw scientific and clinical materials if nothing exists yet. Either way, the starting point is the science rather than a blank slide.

08

Do you offer other life sciences presentation services beyond pitch deck design?

Yes. We design across the full range of life sciences communication needs including medical affairs presentations, KOL and speaker presentations, scientific congress posters, disease awareness materials, medical training presentations, product training presentations, and corporate communications. Each service follows the same in-house production process and is covered by NDA before any materials are shared.

09

Do you work exclusively with life sciences companies, or across other industries?

We work exclusively within life sciences, biotech, medtech, diagnostics, and healthcare. Our designers are medically graduated and our team brings over 20 years of experience working with life sciences organisations, so every project is handled by people who understand the science from the inside, not designers applying a visual layer from the outside.

10

Why use a specialist life sciences pitch deck design service instead of generating one with AI?

AI tools can produce slides quickly but cannot validate clinical data, structure an investment case around a specific development stage, or adapt the commercial narrative to a particular investor audience. A pitch deck built without scientific and commercial oversight carries real credibility risk in a fundraising meeting. Every presentation we build is developed specifically for the science, the fundraising stage, and the investor audience being addressed.